Hiva Kolodrubetz, NP, provides an engaging and detailed session on anti-diabetic medications, focusing on safe prescribing and effective management strategies. Highlighting pharmacological mechanisms, A1C goals, and patient-centered care,…
Associate Professor Mike Todorovic, AKA “Dr. Mike”, introduces the endocrine system, explaining how hormones act as chemical messengers released into the bloodstream by cells, tissues, and glands. He…
NEW YORK (Reuters Health) – In metformin-treated patients with type 2 diabetes, exenatide twice daily improves glycemic control to the same degree as insulin aspart twice daily, but…
NEW YORK (Reuters Health) – Insulin degludec, an ultra-long-acting basal insulin, provides glycemic control in type 1 diabetes similar to that of insulin glargine but with lower occurrence…
NEW YORK (Reuters Health) – Women with polycystic ovary syndrome have increased levels of LDL-cholesterol and non-HDL-cholesterol, as well as more widely recognized alterations in triglycerides and HDL…
NEW YORK (Reuters Health) – Neither injectable nor oral contraceptives have a meaningful effect on glucose or insulin levels, researchers report in the January 2011 Obstetrics & Gynecology.…
NEW YORK (Reuters Health) – In comparison with results in adults with diabetes, hemoglobin A1c (HbA1C) testing in younger patients doesn’t have the same level of discrimination, researchers…
NEW YORK (Reuters Health) – The response rate to high-dose pulsed intravenous glucocorticoid therapy is about 80% for patients with active Graves’ orbitopathy, German clinicians report. However, they…
NEW YORK (Reuters Health) – Basal bolus glargine insulin once daily plus glulisine before meals effectively manages general surgery patients with type 2 diabetes, investigators report. Compared to…
NEW YORK (Reuters Health) – An updated guideline from the American Academy of Neurology recommends plasmapheresis for severe relapses in multiple sclerosis and other inflammatory demyelinating neurologic disorders.…
NEW YORK (Reuters Health) – Depending on the particular regimen, insulin analogs can help 35% to 64% of patients with type 2 diabetes achieve the recommended hemoglobin A1C…
NEW YORK (Reuters Health) – In a small study of pregnant women with type 1 diabetes, use of a closed-loop insulin delivery system (also known as the artificial…
